APA Citation

Davies, M., Leiter, L., Guerci, B., Grunberger, G., Ampudia-Blasco, F., Yu, C., . . . Rosenstock, J. (2017). Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents.

Chicago Style Citation

Davies, MJ, et al. Impact of Baseline Glycated Haemoglobin, Diabetes Duration and Body Mass Index On Clinical Outcomes in the LixiLan-O Trial Testing a Titratable Fixed-ratio Combination of Insulin Glargine/lixisenatide (iGlarLixi) Vs Insulin Glargine and Lixisenatide Monocomponents. 2017.

MLA Citation

Davies, MJ, et al. Impact of Baseline Glycated Haemoglobin, Diabetes Duration and Body Mass Index On Clinical Outcomes in the LixiLan-O Trial Testing a Titratable Fixed-ratio Combination of Insulin Glargine/lixisenatide (iGlarLixi) Vs Insulin Glargine and Lixisenatide Monocomponents. 2017.

Warning: These citations may not always be 100% accurate.